Gammadelta Therapeutics Ltd, London

Gammadelta Therapeutics Ltd is a private limited company. Located at 1 Kingdom Street, London W2 6BD, the above-mentioned 7 years old company was incorporated on 2016-06-17 and is officially classified as "research and experimental development on biotechnology" (Standard Industrial Classification: 72110).
2 directors can be found in this enterprise: Seyda M. (appointed on 01 August 2022), Emma R. (appointed on 05 April 2022). Among the secretaries (1 in total), we can name: Bryan D. (appointed on 05 April 2022).
About
Name: Gammadelta Therapeutics Ltd
Number: 10238425
Incorporation date: 2016-06-17
End of financial year: 31 March
 
Address: 1 Kingdom Street
London
W2 6BD
SIC code: 72110 - Research and experimental development on biotechnology
Company staff
People with significant control
Takeda Pharmaceutical Company Limited
8 May 2017
Address 1-1 Doshomachi 4-Chome Doshomachi 4-Chome, Chuo-Ku, Osaka, 12-10, Japan
Legal authority Japan
Legal form Corporation
Country registered Japan
Place registered Japan Exchange Group
Registration number 1200-01-077461
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors
Abingworth Bioventures Vi Gp Lp
24 July 2017 - 5 April 2022
Address 50 Lothian Road, Festival Square, Edinburgh, Midlothian, EH3 9WJ, Scotland
Legal authority Scottish Law
Legal form Private Limited Partnership
Country registered Scotland
Place registered Companies House Edinburgh
Registration number Sl010733
Nature of control: 25-50% voting rights
right to appoint and remove directors
25-50% shares
Abingworth Llp
15 August 2016 - 24 July 2017
Address 38 Jermyn Street, London, SW1Y 6DN, United Kingdom
Legal authority England And Wales
Legal form Limited Liability Partnership
Country registered England And Wales
Place registered Registrar Of Companies
Registration number Oc320188
Nature of control: right to appoint and remove directors
25-50% shares

The deadline for Gammadelta Therapeutics Ltd confirmation statement filing is 2024-06-30. The most current one was sent on 2023-06-16. The date for the next annual accounts filing is 31 December 2023. Latest accounts filing was sent for the time period up until 31 March 2022.

3 persons of significant control are listed in the Companies House, namely: Takeda Pharmaceutical Company Limited owns over 3/4 of shares, 3/4 to full of voting rights. This corporate PSC is located at Doshomachi 4-Chome, Chuo-Ku, 12-10. Abingworth Bioventures Vi Gp Lp owns 1/2 or less of shares, 1/2 or less of voting rights. This corporate PSC is located at Lothian Road, Festival Square, EH3 9WJ Edinburgh, Midlothian. Abingworth Llp owns 1/2 or less of shares. This corporate PSC is located at Jermyn Street, SW1Y 6DN London.

Company filing
Filter filings by category:
Accounts Address Capital Confirmation statement Incorporation Mortgage Officers Persons with significant control Resolution
Group of companies' report and financial statements (accounts) made up to Thu, 31st Mar 2022
filed on: 3rd, January 2023 | accounts
Free Download (43 pages)